LOADING
Comparing Eli Lilly and Company (LLY) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $948.9B | -- |
| P/E Ratio | 37.7 | -- |
| Forward P/E | 29.9 | -- |
| PEG Ratio | 1.45 | -- |
| EPS | $28.20 | -- |
| Revenue Growth (YoY) | 55.5% | -- |
| Profit Margin | 35.0% | -- |
| Return on Equity | 107.5% | -- |
| Dividend Yield | 0.58% | -- |
| Beta | 0.48 | -- |
| 52-Week High | $1,149.10 | -- |
| 52-Week Low | $619.40 | -- |
| Volume | -- | -- |